Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05135975
Title A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nationwide Children's Hospital
Indications

nephroblastoma

Ewing sarcoma

embryonal rhabdomyosarcoma

Advanced Solid Tumor

diffuse midline glioma, H3 K27M-mutant

neuroblastoma

central nervous system cancer

rhabdoid cancer

central nervous system germ cell tumor

sarcoma

high grade glioma

rhabdomyosarcoma

germ cell cancer

atypical teratoid rhabdoid tumor

osteosarcoma

alveolar rhabdomyosarcoma

medulloblastoma

Therapies

Cabozantinib

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.